Bicocca Open Archive

Logo unimib boa
ANTONAZZO, IPPAZIO COSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.786
NA - Nord America 5.345
EU - Europa 3.529
SA - Sud America 758
Continente sconosciuto - Info sul continente non disponibili 303
AF - Africa 142
OC - Oceania 9
Totale 15.872
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.072
SG - Singapore 1.894
IT - Italia 1.462
VN - Vietnam 1.191
CN - Cina 922
HK - Hong Kong 805
RU - Federazione Russa 602
BR - Brasile 552
DE - Germania 390
IE - Irlanda 205
FR - Francia 195
CA - Canada 168
BD - Bangladesh 162
IN - India 152
KR - Corea 147
GB - Regno Unito 145
SE - Svezia 123
ID - Indonesia 117
FI - Finlandia 79
AR - Argentina 77
NL - Olanda 75
IQ - Iraq 61
ZA - Sudafrica 51
MX - Messico 45
ES - Italia 43
TR - Turchia 41
PH - Filippine 38
AT - Austria 36
SA - Arabia Saudita 36
PL - Polonia 35
JP - Giappone 34
CO - Colombia 31
EC - Ecuador 30
PK - Pakistan 30
UA - Ucraina 29
MY - Malesia 25
VE - Venezuela 24
CH - Svizzera 22
EG - Egitto 18
MA - Marocco 17
UZ - Uzbekistan 17
CL - Cile 15
JM - Giamaica 15
AL - Albania 14
CZ - Repubblica Ceca 14
AE - Emirati Arabi Uniti 13
IR - Iran 13
KE - Kenya 13
TN - Tunisia 13
CR - Costa Rica 10
ET - Etiopia 10
IL - Israele 9
NP - Nepal 9
PY - Paraguay 9
AU - Australia 8
JO - Giordania 8
TW - Taiwan 8
UY - Uruguay 8
DZ - Algeria 6
KZ - Kazakistan 6
PE - Perù 6
PT - Portogallo 6
QA - Qatar 6
TH - Thailandia 6
BE - Belgio 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
HN - Honduras 5
LT - Lituania 5
MN - Mongolia 5
OM - Oman 5
PA - Panama 5
BG - Bulgaria 4
BO - Bolivia 4
HR - Croazia 4
LB - Libano 4
MD - Moldavia 4
PS - Palestinian Territory 4
RO - Romania 4
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
GR - Grecia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
RS - Serbia 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BW - Botswana 2
BZ - Belize 2
CG - Congo 2
GY - Guiana 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MK - Macedonia 2
MU - Mauritius 2
NG - Nigeria 2
Totale 15.541
Salva come PNG Salva come JPEG
Città #
Singapore 1.124
Hong Kong 789
San Jose 650
Ashburn 575
Milan 411
Ho Chi Minh City 367
Ann Arbor 345
Hanoi 323
Hefei 277
Frankfurt am Main 213
Dallas 201
Dublin 195
New York 192
Los Angeles 161
Santa Clara 156
Council Bluffs 141
Seoul 140
The Dalles 139
Chicago 138
Chandler 125
Rome 121
Beijing 103
Toronto 97
Lauterbourg 78
Jakarta 75
São Paulo 71
Buffalo 63
Munich 63
Boardman 62
Moscow 60
London 53
Helsinki 49
Columbus 48
Seattle 48
Nuremberg 43
Bologna 42
Fairfield 42
Princeton 42
Da Nang 38
Haiphong 34
Wilmington 33
Phoenix 32
Ha Long 31
Houston 31
Tokyo 30
Turin 30
Washington 29
Baghdad 28
Rio de Janeiro 27
Brooklyn 26
Denver 26
Orem 26
Perugia 26
Thái Nguyên 26
Verona 26
Warsaw 26
Altamura 25
Biên Hòa 25
Can Tho 23
Ninh Bình 23
Shanghai 23
Parma 22
Florence 21
Naples 21
Salt Lake City 21
Chennai 20
Johannesburg 19
Figino 18
Lappeenranta 18
Lawrence 18
Montreal 18
Palermo 18
Mexico City 17
Woodbridge 17
Atlanta 16
Jeddah 16
Quận Bình Thạnh 16
San Francisco 16
Zurich 16
San Diego 15
Tashkent 15
Vienna 15
Dhaka 14
Hải Dương 14
Osasco 14
Philadelphia 14
Roubaix 14
Cambridge 13
Guangzhou 13
Hangzhou 13
Madrid 13
Mumbai 13
Boston 12
Kent 12
Kuala Lumpur 12
Nairobi 12
Stockholm 12
Amsterdam 11
Brasília 11
Bắc Giang 11
Totale 9.067
Salva come PNG Salva come JPEG
Nome #
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 643
Epidemiology of SLE in Italy: an observational study using a primary care database 569
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 496
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 395
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 378
Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy 335
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 305
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 297
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 288
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 278
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 273
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 267
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 263
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review 261
PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study 257
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 255
Hepatitis B vaccination and the putative risk of central demyelinating diseases – A systematic review and meta-analysis 246
Azithromycin use and covid-19: a real-world observational study. 245
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view 245
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy 245
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 239
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 235
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 234
The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey 233
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 231
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 228
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 225
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973) 221
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 221
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 219
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy 215
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients 212
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up 211
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 207
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy 200
Analisi della variazione del burden dell’inquinamento atmosferico in Italia dal 1990 al 2019: evidenze dai dati del Global Burden of Disease Study 198
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 197
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 196
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 188
Risk management and drug utilization research 188
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 173
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy 170
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study 165
Impact of covid-19 lockdown, during the two waves, on drug use and emergency department access in people with epilepsy: An interrupted time-series analysis 164
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 164
A Multidatabase study of trajectories of antidepressant use in Italy 162
Time trends in the incidence of essential tremor: Evidences from UK and France primary care data 153
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies 152
Impatto dell’epidemia SARS-COV2 sulla gestione dei pazienti affetti da epilessia: un’analisi delle serie storiche interrotte sull’uso degli antiepilettici e l’accesso in pronto soccorso durante le due ondate COVID-19 149
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 149
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region 129
Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis 129
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system 129
Raphanus sativus cv. Sango sprout juice decreases diet-induced obesity in sprague dawley rats and ameliorates related disorders 128
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply 125
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months 123
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 123
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 122
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 122
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems 118
Editorial: Overcoming boundaries in public health: Advances in international and global health 117
The Burden of Chronic Heart Failure in Primary Care in Italy 117
Diabetes is associated with decreased migraine risk: A nationwide cohort study 115
Drug-induced Kounis syndrome: A matter of pharmacovigilance 114
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 113
Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research 113
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study 113
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System 111
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 108
Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice 106
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 105
Real-world evidence and pharmacovigilance: workshop of the Italian Epidemiological Association and of the Italian Society of Pharmacology 104
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 104
Use of antidepressants during COVID19 outbreak: a real-world drug-utilization study 102
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution 101
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list? 99
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 95
Adverse events with sacubitril/valsartan in the real world: Emerging signals to target preventive strategies from the FDA adverse event reporting system 95
Timing of hepatitis B and C virus elimination in Europe: a picture from the Global Burden of Disease Study 2019 86
Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements 86
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 80
Totale 15.872
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.330
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022356 0 0 42 39 49 20 46 23 21 32 37 47
2022/2023834 44 211 69 45 71 72 158 39 41 25 24 35
2023/20241.358 42 80 71 123 162 262 139 64 127 44 105 139
2024/20253.445 173 332 133 189 287 180 249 120 368 490 328 596
2025/20268.248 1.310 790 581 878 816 398 1.108 324 569 637 304 533
2026/20271.197 322 404 471 0 0 0 0 0 0 0 0 0
Totale 15.872